<DOC>
	<DOCNO>NCT01107340</DOCNO>
	<brief_summary>This multicentre post-marketing prospective study evaluate performance clinical outcome AMIIStem primary hip system .</brief_summary>
	<brief_title>AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Hip Dislocation</mesh_term>
	<mesh_term>Hip Dislocation , Congenital</mesh_term>
	<criteria>Patient good candidate primary hip arthroplasty use AMIStem Hip System Patient willing able give inform consent participate followup program Patient suitable surgery able participate followup program . Those present disease meet indication use Medacta implant define study ( onlabel use ) Acute systemic chronic infection Skeletal immaturity Severe muscular , neurological , vascular deficiency pathology affect limb may compromise stability implant . Bone condition may compromise stability implant . Patient unwilling unable give consent , comply protocol followup program .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>